Multiple Sclerosis Trial, By Invitation NCT06874764 Sponsor: Ege University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT06874764
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are between 18 and 55 years old
  • People who have been diagnosed with Multiple Sclerosis (MS) based on a specific set of diagnostic standards known as the 2017 McDonald criteria
  • People whose MS disability level has been measured at 4 or below on a standard scale used by doctors to rate MS-related disability (called the EDSS)
  • People who are able to speak and understand Turkish and have no speech difficulties

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been exercising regularly in the last 6 months
  • People who have had an MS attack (a flare-up of symptoms) within the past month
  • People who experience an MS attack during the study period
  • People who have additional neurological conditions alongside MS
  • People who are currently using a medication called dalfampridine
  • People who are currently using antipsychotic or psychostimulant medications
  • People who have a drug or alcohol addiction
  • People who are pregnant or breastfeeding
  • People who do not have a chronic illness or physical condition that would prevent them from exercising (confirm with trial site)
  • People who are unable to reach the target level of exercise set by the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Ege University
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 May 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Cognitive Functions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov